Cargando…
Emerging Role of EGFR Mutations in Creating an Immune Suppressive Tumour Microenvironment
Several types of tumours overexpress the Epidermal Growth Factor Receptor (EGFR) in either wild type or mutated form. These tumours are often highly aggressive and difficult to treat. The underlying mechanisms for this phenomenon have remained largely unresolved, but recent publications suggest two...
Autores principales: | Kapoor, Simran S., Zaiss, Dietmar M. W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8772868/ https://www.ncbi.nlm.nih.gov/pubmed/35052732 http://dx.doi.org/10.3390/biomedicines10010052 |
Ejemplares similares
-
The Immune System's Contribution to the Clinical Efficacy of EGFR Antagonist Treatment
por: MacDonald, Felicity, et al.
Publicado: (2017) -
Tumour Microenvironment and Immune Evasion in EGFR Addicted NSCLC: Hurdles and Possibilities
por: Santaniello, Antonio, et al.
Publicado: (2019) -
The immune microenvironment in EGFR- and ERBB2-mutated lung adenocarcinoma
por: Kirchner, M., et al.
Publicado: (2021) -
Favorable Immune Microenvironment in Patients with EGFR and MAPK Co-Mutations
por: Yang, Wang, et al.
Publicado: (2020) -
EGFR Inhibition Strongly Modulates the Tumour Immune Microenvironment in EGFR-Driven Non-Small-Cell Lung Cancer
por: Selenz, Carolin, et al.
Publicado: (2022)